1 gen 2014 anni - FDA approves two immunotherapies for melanoma
Descrizione:
FDA grants accelerated approval to pembrolizumab and nivilumab for patients with advanced melanoma that can no longer be removed by surgery.
Aggiunto al nastro di tempo:
Data: